Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dan Bradbury
AddedMar 31, 2024
UpdatedJun 28, 2026
Dan Bradbury

Dan Bradbury

Founder, Biobrit

CrunchbaseLinkedIn

Dan Bradbury's Career

Biobrit
Biobrit

Los Angeles, CA, US

Founder
Biocon
Biocon

Bangalore, Karnataka, IN

Board Member· Board
Equillium
Equillium

Los Angeles, CA, US

Board Member· Board
Castle Biosciences
Castle Biosciences

Friendswood, TX, US

Board Member· Board
Intercept Pharmaceuticals
Intercept Pharmaceuticals

New York City, NY, US

Board Member· Board
Amplo Biotechnology
Amplo Biotechnology

Pompano Beach, FL, US

Board Member· Board
Sensulin
Sensulin

Oklahoma City, OK, US

Board Member· Board
Microdermis
Microdermis

Princeton, NJ, US

Board Member· Board
Neurovia
Neurovia

San Francisco, CA, US

Board Member· Board
Thesan Pharmaceuticals
Thesan Pharmaceuticals

San Clemente, CA, US

Board Member· Board
Biolinq
Biolinq

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dan Bradbury's Career

Biobrit
Biobrit
Investment FirmInvestment Firm62012Los Angeles, CA, US
Founder
Biocon
Biocon

Bangalore, Karnataka, IN

Board Member· Board
Equillium
Equillium

Los Angeles, CA, US

Board Member· Board
Castle Biosciences
Castle Biosciences
Public$354.3M5432008Friendswood, TX, US
Board Member· Board

Leadership at Castle Biosciences

G. Bradley ColeG. Bradley ColeBoard Member
Tiffany OlsonTiffany OlsonBoard Member
Mr. Derek J. MaetzoldMr. Derek J. MaetzoldFounder
Bonnie AndersonBonnie AndersonBoard Member
Mara AspinallMara AspinallBoard Member
Garheng KongGarheng KongBoard Member

Similar to Castle Biosciences

Predictive BiosciencesPredictive BiosciencesLexington, KY, USCancer Testsest. 2006Predictive BiosciencesLexington, KY, US · est. 2006

Predictive Biosciences develops molecular tests and technologies for cancer diagnosis and monitoring in the US.

Pre-Seed · $68.1M75
BiodesixBiodesixBoulder, CO, USDiagnostic Testsest. 2005BiodesixBoulder, CO, US · est. 2005

Biodesix, Inc.: A leading biotech firm providing data-driven diagnostic solutions and lab tests in the US.

Public · $390.3M245
Caris Life SciencesCaris Life SciencesIrving, TX, USCancer Diagnosticsest. 1996Caris Life SciencesIrving, TX, US · est. 1996

US-based Caris Life Sciences specializes in innovative biotech solutions for cancer diagnosis and treatment.

Public · $1.7B1.5k
Intercept Pharmaceuticals
Intercept Pharmaceuticals

New York City, NY, US

Board Member· Board
Amplo Biotechnology
Amplo Biotechnology
Seed$2.2M62019Pompano Beach, FL, US
Board Member· Board

Leadership at Amplo Biotechnology

Patricio SepulvedaPatricio SepulvedaCEO
Sensulin
Sensulin

Oklahoma City, OK, US

Board Member· Board
Microdermis
Microdermis

Princeton, NJ, US

Board Member· Board
Neurovia
Neurovia
Public$14M752013San Francisco, CA, US
Board Member· Board

Leadership at Neurovia

Giovanni FerraraGiovanni FerraraBoard Member
Henry B. SkinnerHenry B. SkinnerBoard Member
Jason P. HaflerJason P. HaflerBoard Member

Similar to Neurovia

Neurona TherapeuticsNeurona TherapeuticsSouth San Francisco, CA, USCell Therapiesest. 2008Neurona TherapeuticsSouth San Francisco, CA, US · est. 2008

Neurona Therapeutics: Leading provider of cell-based medicines for neurological disorders.

Series A · $200.3M58
Neuron23Neuron23South San Francisco, CA, USPrecision Medicinesest. 2018Neuron23South San Francisco, CA, US · est. 2018

Neuron23™ Inc.: Developing precision medicines for specific neurological and immunological diseases.

Series C · $213.5M61
Thesan Pharmaceuticals
Thesan Pharmaceuticals

San Clemente, CA, US

Board Member· Board
Biolinq
Biolinq
Series D$196.3M882015San Diego, CA, US
Board Member· Board

Leadership at Biolinq

Edward KliphuisEdward KliphuisBoard Member
Joshua WindmillerJoshua WindmillerCo-Founder
Jared TangneyJared TangneyCo-Founder
Richard YangRichard YangCEO
Lana GhanemLana GhanemBoard Member

Dan Bradbury's Co-Investors

Chrysa MineoChrysa MineoCo-invested · Alume Biosciences Series A

Dan Bradbury's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Dan Bradbury

Dan LynchDan LynchBoard Member · 2seventy bioBrad LaPrayBrad LaPrayBoard Member · BioLogiQChris MasonChris MasonBoard Member · Krystal BiotechDan KidleDan KidleBoard Member · Jumpcode Genomics